The Magazine for Sleep Professionals
Saturday, October 17, 2026
Alkermes plc announced plans to present two oral presentations and six posters from its industry-leading portfolio of sleep medicine research at the European Sleep Research Society’s (ESRS) 28th Congress, Sleep Europe 2026, taking place Oct. 20-23, 2026 in Maastricht, the Netherlands. The company will present new data related to LUMRYZ® […]
Takeda announced that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the […]
Carnyx Therapeutics Ltd. unveiled CNYX-005, its lead oral sleep candidate, alongside preclinical findings showing increased total sleep time and non-rapid eye movement (NREM) sleep in aged animal models. In the study, aged rats administered with CNYX-005 showed an approximately 1.5- to 2-hour increase in total sleep time compared to the control […]
The BRPT is excited to again offer a tuition grant to a promising student of polysomnography. The scholarship award is up to $3,000 toward tuition costs or the actual cost of tuition as invoiced from the education provider, whichever is less. The scholarship is named in honor of Jomo Martin […]
Inspire Medical Systems, Inc. announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, […]
We’re happy to announce that we’ve received our Phase I Small Business Innovation Research (SBIR) award from the National Institutes of Health, through the National Heart, Lung, and Blood Institute (NHLBI). This award supports real-world testing of our in-ear sensor system for in-lab and ambulatory sleep monitoring, along with the […]
sovaSage, Inc., an AI-powered patient management technology company focused on sleep therapy, announced the next milestone in the phased development of Jeanie™, advancing an agentic AI strategy that has been part of the company’s vision for intelligent patient management from the beginning. For sovaSage, agentic AI is not a new […]
Lilly announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with type 2 diabetes and obesity or overweight. At 80 weeks, all doses of retatrutide (4 mg, 9 mg, and […]
BMC Medical Co., Ltd. has recalled its Luna G3 APAP device (model LG3600) due to a firmware defect that can cause the machine to display an error message and shut down automatically, cutting off therapy delivery, the U.S. Food and Drug Administration announced. The FDA has classified the action as […]
Frost & Sullivan is pleased to announce that SleepRes has been recognized with the 2026 North America New Product Innovation Recognition in the Positive Airway Pressure Devices industry for its outstanding achievements in product innovation, clinical differentiation, and patient-centric therapy design. This recognition highlights SleepRes’ leadership in advancing measurable clinical […]
